Search

Thomas D Gootz

from Estes Park, CO
Age ~73

Thomas Gootz Phones & Addresses

  • 2855 Grey Fox Dr, Estes Park, CO 80517 (970) 586-9257
  • 14 Dickinson Ct, Deep River, CT 06417 (860) 526-4541
  • Westbrook, CT
  • Niantic, CT
  • Groton, CT
  • 2855 Grey Fox Dr, Estes Park, CO 80517

Work

Position: Executive, Administrative, and Managerial Occupations

Education

Degree: Bachelor's degree or higher

Resumes

Resumes

Thomas Gootz Photo 1

Pharmaceutical Infectious Diseases Consultant

View page
Location:
2855 Grey Fox Dr, Estes Park, CO 80517
Industry:
Pharmaceuticals
Work:
Thomas Gootz Consulting since Jan 2009
Pharmaceutical Infectious Diseases Consultant

AstraZeneca - Massachusetts Jan 2011 - Oct 2012
Consultant FDA, EMA, Canadian Product Indications

Pfizer Inc. 1983 - Jan 2009
Senior Research Fellow

University of Washington 1981 - 1983
Postdoctoral Fellow
Education:
University of Washington School of Medicine 1981 - 1983
Post Doc, Microbiology and Infectious Diseases
Skills:
Drug Discovery
Thomas Gootz Photo 2

Pharmaceutical Infectious Diseases Consultant At Thomas Gootz Consulting

View page
Position:
Pharmaceutical Infectious Diseases Consultant at Thomas Gootz Consulting
Location:
Estes Park, Colorado
Industry:
Pharmaceuticals
Work:
Thomas Gootz Consulting since Jan 2009
Pharmaceutical Infectious Diseases Consultant

AstraZeneca - Massachusetts Jan 2011 - Oct 2012
Consultant FDA, EMA, Canadian Product Indications

Pfizer Inc. 1983 - Jan 2009
Senior Research Fellow

University of Washington 1981 - 1983
Postdoctoral Fellow
Education:
University of Washington School of Medicine 1981 - 1983
Post Doc, Microbiology and Infectious Diseases
Skills:
Drug Discovery

Publications

Us Patents

Treatment Of H. Pylori Infections

View page
US Patent:
57287112, Mar 17, 1998
Filed:
Dec 2, 1996
Appl. No.:
8/764655
Inventors:
Arthur E. Girard - Jewett City CT
Thomas D. Gootz - Deep River CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31435
US Classification:
514300
Abstract:
An infection with Helicobacter may successfully be treated with a compound of the formula ##STR1## wherein R. sub. 1 is hydrogen or methyl and R. sub. 2 is hydrogen or L-alanine-L-alanyl, and the pharmaceutically acceptable acid additive salts thereof. These compounds are useful in the treatment of gastric and duodenal ulcers.
Thomas D Gootz from Estes Park, CO, age ~73 Get Report